BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2107346)

  • 1. [Idiopathic thrombocytopenic purpura complicated with circulating lupus anticoagulant].
    Saito K; Ishiyama T; Hashimoto M; Osawa H; Koike M; Sugimoto M; Horie S; Wakabayashi Y; Hirose S
    Rinsho Ketsueki; 1990 Jan; 31(1):52-6. PubMed ID: 2107346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abnormality of blood coagulation in idiopathic thrombocytopenic purpura (ITP)].
    Wada H; Deguchi A; Mori Y; Ohkubo I; Tsuda M; Nagano T; Tsuzi K; Yamaguchi T; Minami N; Deguchi K
    Rinsho Ketsueki; 1987 Mar; 28(3):338-44. PubMed ID: 3112443
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection and quantitative evaluation of lupus circulating anticoagulant activity.
    Rosner E; Pauzner R; Lusky A; Modan M; Many A
    Thromb Haemost; 1987 Apr; 57(2):144-7. PubMed ID: 3110995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lupus anticoagulant neutralization procedure using the patient's own platelets.
    Carroll P; Ray M; Just S; Hawson G
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):523-7. PubMed ID: 7841308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenic purpura in a patient with lupus anticoagulant: requirement of both immunosuppressive and antithrombotic therapies.
    Iwahara Y; Niiya K; Yamato K; Miyoshi I
    Am J Hematol; 1990 Jan; 33(1):75-7. PubMed ID: 2104559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
    Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
    Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating anticoagulants and pregnancy: a risky combination].
    Dantal J; Dantal F; Sagot P; Lopes P; Lerat MF
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(3):317-24. PubMed ID: 3135300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lupus anticoagulant antibody (LAC) and juvenile cerebral ischemic attack: a clinical case].
    Menabue R; Bonito V; Nichelli P
    Riv Neurol; 1989; 59(6):203-6. PubMed ID: 2517906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transitions of each inhibitor in a patient with lupus anticoagulant and anti-prothrombin antibody].
    Murakami F; Iijima K; Nakamura K; Ikawa S; Hayashibara H; Siraki K
    Rinsho Byori; 1996 Jul; 44(7):692-6. PubMed ID: 8741501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities].
    Raleigh-Rosendo R; Diez-Ewald M; VizcaĆ­no G; Fereira H; Arteaga-VizcaĆ­no M; Arreaza M
    Invest Clin; 1990; 31(1):45-55. PubMed ID: 2128614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis].
    Arai M
    Rinsho Byori; 2004 Feb; 52(2):178-81. PubMed ID: 15027324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual case of Hansen's disease (lepromatous leprosy) with circulating anticoagulant and macroglobulinemia.
    Desai RG
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):462-5. PubMed ID: 2119410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor].
    Komiyama Y; Munakata M; Masuda M; Kagawa H; Fukuhara S; Takahashi H
    Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus anticoagulant testing: effect of the platelet count on the activated partial thromboplastin time.
    Brien WF; Schaus MR; Cooper KE; O'Keefe BT; Inwood M
    Br J Biomed Sci; 1993 Jun; 50(2):114-6. PubMed ID: 8219916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids.
    Rauch J; Tannenbaum M; Janoff AS
    Thromb Haemost; 1989 Nov; 62(3):892-6. PubMed ID: 2512678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of lupus-like anticoagulants by an enzyme-linked immunosorbent assay using a partial thromboplastin as antigen; a comparative study.
    Arnout J; Huybrechts E; Vanrusselt M; Falcon C; Vermylen J
    Thromb Haemost; 1990 Aug; 64(1):26-31. PubMed ID: 2125756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of prolonged APTT and lupus anticoagulant in autoimmune thyroid disease].
    Tani Y; Morita M; Noguchi S
    Rinsho Byori; 1997 Sep; 45(9):899-902. PubMed ID: 9311265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.